Rosenman Herm
SEC-identified person · CIK 1230057 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Natera, Inc. NTRA | Director · Chief Financial Officer | filed 2015–2026 |
| Dermtech, Inc. DMTK | Director | filed 2019–2023 |
| Oxford Immunotec Global PLC OXFD | Director | filed 2013–2021 |
| Vivus INC vvus | Director | filed 2013–2020 |
| Medistem Laboratories, INC. mdsm.ob | Director | filed 2013–2013 |
| GEN Probe INC GPRO | VP, Finance & CFO | filed 2006–2012 |
| Aryx Therapeutics, Inc. ARYX | Director | filed 2007–2010 |
| Infinity Pharmaceuticals, INC. INFI | Director | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.